<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">2985190R</journal-id>
<journal-id journal-id-type="pubmed-jr-id">5004</journal-id>
<journal-id journal-id-type="nlm-ta">J Neurochem</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Neurochem.</journal-id>
<journal-title-group>
<journal-title>Journal of neurochemistry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-3042</issn>
<issn pub-type="epub">1471-4159</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29364507</article-id>
<article-id pub-id-type="pmc">6576257</article-id>
<article-id pub-id-type="doi">10.1111/jnc.14311</article-id>
<article-id pub-id-type="manuscript">NIHMS936724</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Decreased rates of cerebral protein synthesis measured <italic>in vivo</italic> in a mouse model of Tuberous Sclerosis Complex: unexpected consequences of reduced tuberin</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Saré</surname>
<given-names>R. Michelle</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Tianjian</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Burlin</surname>
<given-names>Tom</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Loutaev</surname>
<given-names>Inna</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Smith</surname>
<given-names>Carolyn Beebe</given-names>
</name>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<aff id="A1">Section on Neuroadaptation and Protein Metabolism, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, United States</aff>
</contrib-group>
<author-notes>
<corresp id="FN1"><label>*</label>Corresponding Author: Carolyn Beebe Smith, <email>beebe@mail.nih.gov</email>, 10 Center Drive, Room 2D56, Bethesda, MD 20814, Phone: 301-402-3120, Fax: 301-480-1668</corresp>
<fn fn-type="COI-statement" id="FN5">
<p>Conflicts of interest: None</p>
<p>=&gt; if ‘none’, insert “The authors have no conflict of interest to declare.”</p>
<p>=&gt; otherwise insert info unless it is already included</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>7</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>02</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>17</day>
<month>6</month>
<year>2019</year>
</pub-date>
<volume>145</volume>
<issue>5</issue>
<fpage>417</fpage>
<lpage>425</lpage>
<!--elocation-id from pubmed: 10.1111/jnc.14311-->
<abstract id="Abs1">
<p id="P1">Tuberous Sclerosis Complex (TSC) is an autosomal dominant neurogenetic disorder affecting about 1 in 6,000 people and caused by mutations in either <italic>TSC1</italic> or <italic>TSC2</italic>. This disorder is characterized by increased activity of mammalian target of rapamycin complex 1 (mTORC1), which is involved in regulating ribosomal biogenesis and translation initiation. We measured the effects of <italic>Tsc2</italic> haploinsufficiency (<italic>Tsc2<sup>+/−</sup></italic>) in three month old male mice on regional rates of cerebral protein synthesis (rCPS) by means of the <italic>in vivo</italic> L-[1-<sup>14</sup>C]leucine method. This quantitative autoradiographic method includes an estimate of the integrated specific activity of the tracer amino acid in brain tissue. The estimate accounts for recycling of unlabeled amino acids from tissue protein breakdown by means of a factor (λ) that was determined in control and <italic>Tsc2<sup>+/−</sup></italic> mice. The value of λ was higher in <italic>Tsc2<sup>+/−</sup></italic> mice, indicating that a greater fraction of leucine in the tissue precursor pool for protein synthesis is derived from the plasma compared to controls, consistent with reduced rates of protein degradation. We determined rCPS in freely-moving, awake male <italic>Tsc2<sup>+/−</sup></italic> and control mice, and we used the determined values of λ in the calculation of rCPS. Unexpectedly, we found that rCPS were significantly decreased in 16 of the 17 brain regions analyzed in <italic>Tsc2<sup>+/−</sup></italic> mice compared to controls. Our results indicate a complex role of mTORC1 in the regulation of cerebral protein synthesis that has not been previously recognized.</p>
</abstract>
<abstract abstract-type="graphical" id="Abs2">
<title>Graphical abstract</title>
<p id="P2">Tuberous Sclerosis Complex (TSC) is a neurogenetic disorder caused by mutations in either <italic>TSC1</italic> or <italic>TSC2</italic> and characterized by epilepsy, intellectual disability, and autism spectrum disorders. TSC1 and TSC2 form a complex that inhibits mammalian target of rapamycin complex 1 (mTORC1), a key regulatory hub in cell signaling. Among other processes, mTORC1 regulates cellular protein synthesis. We hypothesized that rates of cerebral protein synthesis (rCPS) would be increased in mice haploinsufficient for <italic>Tsc2</italic>. Contrary to our hypothesis, our results indicate that rCPS are decreased throughout the brain in haploinsufficient <italic>Tsc2</italic> mice, suggesting a more complex role of mTORC1 in the regulation of cerebral protein synthesis than previously recognized.</p>
<p id="P3">
<graphic orientation="portrait" position="anchor" xlink:href="nihms936724u1.jpg"></graphic></p>
</abstract>
<kwd-group>
<kwd>Tuberous Sclerosis Complex</kwd>
<kwd>mTOR</kwd>
<kwd>protein synthesis</kwd>
<kwd>protein degradation</kwd>
<kwd>translation</kwd>
<kwd>autoradiography</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>